Clinical implications of the PROTECT-TIMI-30 trial. - Suppr | 超能文献

Clinical implications of the PROTECT-TIMI-30 trial.

作者信息

Valgimigli Marco, Biondi-Zoccai Giuseppe G L, Agostoni Pierfrancesco

出版信息

J Am Coll Cardiol. 2007 Feb 13;49(6):729-30; author reply 730-1. doi: 10.1016/j.jacc.2006.11.012. Epub 2007 Jan 26.

DOI:10.1016/j.jacc.2006.11.012

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Clinical implications of the PROTECT-TIMI-30 trial.

J Am Coll Cardiol. 2007 Feb 13;49(6):729-30; author reply 730-1. doi: 10.1016/j.jacc.2006.11.012. Epub 2007 Jan 26.

2

Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.

J Am Coll Cardiol. 2008 May 27;51(21):2028-33. doi: 10.1016/j.jacc.2008.04.002.

3

The evolving algorithm concerning higher-risk PCI (TEACH-PCI). Introduction.

Rev Cardiovasc Med. 2007;8 Suppl 3:S1-2.

4

[Anticoagulants and antiaggregants in ischemic heart disease].

G Ital Cardiol. 1990 Aug;20(8):746-57.

5

What physicians should know about coronary stents.

Minn Med. 2008 Jan;91(1):44-6.

6

Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.

Circulation. 2009 Jun 2;119(21):2758-64. doi: 10.1161/CIRCULATIONAHA.108.833665. Epub 2009 May 18.

7

[Antiplatelets and anticoagulants in acute coronary syndromes: levels of evidence].

Rev Med Univ Navarra. 2007 Jan-Mar;51(1):23-7.

8

[Coronary angioplasty: the old and new indications].

Rev Esp Cardiol. 1993;46 Suppl 3:15-20.

9

[Unstable coronary artery diseases: risk categorization and treatment strategies].

Zhonghua Nei Ke Za Zhi. 2001 May;40(5):293-5.

10

[Angina pectoris and myocardial infarction].

Rev Prat. 2007 May 31;57(10):1139-50.

引用本文的文献

1

How an Aggressive Treatment of No-reflow Phenomenon in Primary Percutaneous Coronary Intervention with High Thrombus Burden can Achieve a Grade III TIMI-flow: A Case Report.

Int J Angiol. 2023 Apr 10;34(3):233-237. doi: 10.1055/s-0043-1764475. eCollection 2025 Sep.